Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH
9 search results for:

WCLC 2021 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 14-09-2021 | WCLC 2021 | Conference coverage | Article

    Flexibility positively impacts lung cancer clinical trial participation in COVID-19 era

    Strategies to improve flexibility in clinical trials may improve enrollment rates during and after the COVID-19 pandemic, according to a study presented at the IASLC 2021 World Conference on Lung Cancer.

    Author:
    Hannah Kitt
    Published in:
    IASLC 2021 World Conference on Lung Cancer; 8–14 September
  2. 14-09-2021 | WCLC 2021 | Conference coverage | Article

    No new safety signals for neoadjuvant, maintenance atezolizumab in mesothelioma

    Tsao presented the findings of the safety and feasibility trial at the IASLC 2021 World Conference on Lung Cancer.

    Author:
    Laura Cowen
    Published in:
    IASLC 2021 World Conference on Lung Cancer; 8–14 September
  3. 09-09-2021 | WCLC 2021 | Conference coverage | Article

    Durvalumab–tremelimumab plus chemo ‘a potential new first-line option’ for metastatic NSCLC

    The rates of discontinuation due to TRAEs in the three groups were 14.1%, 15.5%, and 9.9%, respectively, with TRAE-related deaths in 2.1%, 3.3%, and 2.4%. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group IASLC 2021 World Conference on Lung Cancer; 8–14 September

    Author:
    Shreeya Nanda
    Published in:
    IASLC 2021 World Conference on Lung Cancer; 8–14 September
  4. 13-09-2021 | WCLC 2021 | Conference coverage | Article

    ​​​​​​​Pretreatment ctDNA levels may predict survival in neoadjuvant-treated NSCLC patients

    The findings were presented by Atocha Romero (Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain) at the IASLC 2021 World Conference on Lung Cancer.

    Author:
    Shreeya Nanda
    Published in:
    IASLC 2021 World Conference on Lung Cancer; 8–14 September
  5. 13-09-2021 | WCLC 2021 | Conference coverage | Article

    Atezolizumab plus chemotherapy feasible for NSCLC with brain metastases

    The results of the ATEZO-BRAIN trial were presented at the IASLC 2021 World Conference on Lung Cancer by Ernest Nadal from the Institut Català d’Oncologia – L’Hospitalet in Barcelona, Spain.

    Author:
    Laura Cowen
    Published in:
    IASLC 2021 World Conference on Lung Cancer; 8–14 September
  6. 10-09-2021 | WCLC 2021 | Conference coverage | Article

    No OS benefit of lurbinectedin plus doxorubicin in relapsed SCLC

    For instance, the respective rates of thrombocytopenia of this severity were 13.9% and 31.1%, while anemia occurred in 14.5% and 31.1% of patients and neutropenia in 37.0% and 69.2%. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group IASLC 2021 World Conference on Lung Cancer; 8–14 September

    Author:
    Shreeya Nanda
    Published in:
    IASLC 2021 World Conference on Lung Cancer; 8–14 September
  7. 02-02-2021 | COVID-19 | News | Article
    WCLC 2020

    Psychological distress high in patients with cancer during COVID-19 pandemic

    IASLC 2020 World Conference on Lung Cancer; 28–31 January 2021

    Author:
    Hannah Kitt
    Published in:
    IASLC 2020 World Conference on Lung Cancer; 28–31 January 2021
  8. 05-02-2021 | Non-small-cell lung cancer | News | Article
    WCLC 2020

    Emerging options for NSCLC with rare EGFR mutations

    . © 2021 Springer Healthcare Ltd, part of the Springer Nature Group IASLC 2020 World Conference on Lung Cancer; 28–31 January 2021

    Author:
    Shreeya Nanda
    Published in:
    IASLC 2020 World Conference on Lung Cancer; 28–31 January 2021
  9. 04-02-2021 | Mesothelioma | News | Article
    WCLC 2020

    Real-world data support carboplatin use in malignant pleural mesothelioma

    . © 2021 Springer Healthcare Ltd, part of the Springer Nature Group IASLC 2020 World Conference on Lung Cancer; 28–31 January 2021

    Author:
    Hannah Kitt
    Published in:
    IASLC 2020 World Conference on Lung Cancer; 28–31 January 2021
  • 1

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.